Journal of Antimicrobial Chemotherapy (1995) 35, 345-348
© 1995 The British Society for Antimicrobial Chemotherapy
brief-report |
Mutation position and type of substitution in the ß-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis
Institute for Medical Microbiology, University of Berne CH-3010 Bern, Switzerland
Received 14 June 1994; returned 1 September 1994; accepted 3 October 1994
Quantitative susceptibility testing for rifampicin, rifabutin and rifapentine of 36 Mycobacterium tuberculosis isolates with known sequences for the gene encoding for the RNA polymerase ß-subunit (rpoB)revealed that both mutation position and type of amino acid substitution influence the in-vitro activity of rifamycins in rifampicin-resistant strains.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Cavusoglu, A. Turhan, P. Akinci, and I. Soyler Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Isolates. J. Clin. Microbiol., July 1, 2006; 44(7): 2338 - 2342. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jureen, L. Engstrand, S. Eriksson, A. Alderborn, M. Krabbe, and S. E. Hoffner Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis by Pyrosequencing Technology. J. Clin. Microbiol., June 1, 2006; 44(6): 1925 - 1929. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Nikolayevsky, T. Brown, Y. Balabanova, M. Ruddy, I. Fedorin, and F. Drobniewski Detection of Mutations Associated with Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Isolates from Samara Region, Russian Federation J. Clin. Microbiol., October 1, 2004; 42(10): 4498 - 4502. [Abstract] [Full Text] [PDF] |
||||
![]() |
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 603 - 662. [Full Text] [PDF] |
||||
![]() |
L. Qian, C. Abe, T.-P. Lin, M.-C. Yu, S.-N. Cho, S. Wang, and J. T. Douglas rpoB Genotypes of Mycobacterium tuberculosis Beijing Family Isolates from East Asian Countries J. Clin. Microbiol., March 1, 2002; 40(3): 1091 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Klein, T. J. Brown, and G. L. French Rifampin Resistance in Mycobacterium kansasii Is Associated with rpoB Mutations Antimicrob. Agents Chemother., November 1, 2001; 45(11): 3056 - 3058. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bemer-Melchior, A. Bryskier, and H. B. Drugeon Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex J. Antimicrob. Chemother., October 1, 2000; 46(4): 571 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Myers and C. R. Myers Role of the Tetraheme Cytochrome CymA in Anaerobic Electron Transport in Cells of Shewanella putrefaciens MR-1 with Normal Levels of Menaquinone J. Bacteriol., January 1, 2000; 182(1): 67 - 75. [Abstract] [Full Text] |
||||
![]() |
T. A. Wichelhaus, V. Schäfer, V. Brade, and B. Böddinghaus Molecular Characterization of rpoB Mutations Conferring Cross-Resistance to Rifamycins on Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., November 1, 1999; 43(11): 2813 - 2816. [Abstract] [Full Text] |
||||
![]() |
T. Padayachee and K. P. Klugman Molecular Basis of Rifampin Resistance in Streptococcus pneumoniae Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2361 - 2365. [Abstract] [Full Text] |
||||
![]() |
V. Sintchenko, P. J. Jelfs, W. K. Chew, and G. L. Gilbert Mycobacterium tuberculosis rpoB gene DNA sequencing: implications for detection of rifamycin resistance J. Antimicrob. Chemother., August 1, 1999; 44(2): 294 - 295. [Full Text] [PDF] |
||||
![]() |
Z. Fang, C. Doig, A. Rayner, D. T. Kenna, B. Watt, and K. J. Forbes Molecular Evidence for Heterogeneity of the Multiple-Drug-Resistant Mycobacterium tuberculosis Population in Scotland (1990 to 1997) J. Clin. Microbiol., April 1, 1999; 37(4): 998 - 1003. [Abstract] [Full Text] |
||||
![]() |
A Telenti Genetics and pulmonary medicine bullet 5: Genetics of drug resistant tuberculosis Thorax, September 1, 1998; 53(9): 793 - 797. [Full Text] |
||||
![]() |
D. L. Williams, L. Spring, L. Collins, L. P. Miller, L. B. Heifets, P. R. J. Gangadharam, and T. P. Gillis Contribution of rpoB Mutations to Development of Rifamycin Cross-Resistance in Mycobacterium tuberculosis Antimicrob. Agents Chemother., July 1, 1998; 42(7): 1853 - 1857. [Abstract] [Full Text] |
||||
![]() |
S. A. Watterson, S. M. Wilson, M. D. Yates, and F. A. Drobniewski Comparison of Three Molecular Assays for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis J. Clin. Microbiol., July 1, 1998; 36(7): 1969 - 1973. [Abstract] [Full Text] |
||||
![]() |
W. R. Bishai, N. M.H. Graham, S. Harrington, C. Page, K. Moore-Rice, N. Hooper, and R. E. Chaisson Rifampin-Resistant Tuberculosis in a Patient Receiving Rifabutin Prophylaxis N. Engl. J. Med., June 13, 1996; 334(24): 1573 - 1576. [Full Text] [PDF] |
||||






